CD274 and carcinoma of esophagus: In summary, our large cohort study, including more than 400 cases, revealed that PD-L2 expression, as well as PD-L1, was associated with an unfavourable clinical outcome in oesophageal cancer, supporting the role of PD-L2 as a prognostic biomarker.